Combination Therapy of Ezetimibe and Rosuvastatin for Dyslipidemia: Current Insights
Maya R Chilbert,1,2 Dylan VanDuyn,3 Sara Salah,1 Collin M Clark,1,2 Qing Ma1 1Department of Pharmacy Practice, School of Pharmacy and Pharmaceutical Sciences, University at Buffalo, Buffalo, NY, USA; 2Department of Pharmacy, Buffalo General Medical Center, Buffalo, NY, USA; 3Department of Pharmacy,...
Main Authors: | Chilbert MR, VanDuyn D, Salah S, Clark CM, Ma Q |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2022-07-01
|
Series: | Drug Design, Development and Therapy |
Subjects: | |
Online Access: | https://www.dovepress.com/combination-therapy-of-ezetimibe-and-rosuvastatin-for-dyslipidemia-cur-peer-reviewed-fulltext-article-DDDT |
Similar Items
-
Features of using of a fixed combination of rosuvastatin and ezetimibe for effective hypolipidemic therapy
by: I. A. Alekseeva, et al.
Published: (2020-10-01) -
Dyslipidemia Exacerbates Meibomian Gland Dysfunction: A Systematic Review and Meta-Analysis
by: Yasufumi Tomioka, et al.
Published: (2023-03-01) -
A machine learning approach to personalized predictors of dyslipidemia: a cohort study
by: Guadalupe Gutiérrez-Esparza, et al.
Published: (2023-09-01) -
Editorial: Rare dyslipidemias
by: Fouzia Sadiq, et al.
Published: (2023-07-01) -
Effect of the Association of Fixed Oils from <i>Abelmoschus esculentus</i> (L.) Moench, <i>Euterpe oleracea</i> Martius, <i>Bixa orellana</i> Linné and Chronic SM<sup>®</sup> on Atherogenic Dyslipidemia in Wistar Rats
by: Priscila Faimann Sales, et al.
Published: (2023-09-01)